David Linetsky - 21 Apr 2025 Form 4 Insider Report for Phreesia, Inc. (PHR)

Role: SVP, Life Sciences
Signature: /s/ Allison Hoffman by Power of Attorney for David Linetsky
Issuer symbol: PHR
Transactions as of: 21 Apr 2025
Transactions value $: -$5,991
Form type: 4
Filing time: 23 Apr 2025, 16:24:34 UTC
Previous filing: 17 Apr 2025
Next filing: 20 Jun 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PHR	Common Stock	Sale	-$5.99K	-260	-2.89%	$23.04	8.75K	21 Apr 2025	By Spouse	F1, F2
holding	PHR	Common Stock						217K	21 Apr 2025	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units.
F2	The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.75 to $23.675 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.75 to $23.675 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.